rinary Risk Indicators for Novel Evaluation of Diabetic Kidney Disease in type 2 diabetes
Not Applicable
- Conditions
- Health Condition 1: N181- Chronic kidney disease, stage 1Health Condition 2: N182- Chronic kidney disease, stage 2 (mild)Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2024/08/072370
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All consecutive adult patients (age = 18 years). Clinically Diagnosed with CKD as per KDIGO guidelines (CKD stage 1-3) based on CKD-EPI equation in type 2 DM visiting the out-patient clinics of the department of Nephrology, Endocrinology and Medicine.
Exclusion Criteria
Those with CKD stage 4-5, urinary tract infection, inflammatory disorder, allergic disorder, cancer, autoimmune disorder, CKD plus superimposed with non-DM kidney disease, systemic connective tissue disorder and those under nephrotoxic medication.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rapid decline of GFRTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method MortalityTimepoint: 1 year;Onset of Cardiovascular diseases or coronary artery diseases or peripheral vascular diseaseTimepoint: 6 months;Onset of diabetic retinopathy or peripheral neuropathyTimepoint: 6 months;Worsening of proteinuriaTimepoint: 1 year